HCA Healthcare's (HCA) Q2 Earnings Beat Estimates, Fall Y/Y

In this article:

HCA Healthcare, Inc. HCA reported second-quarter 2020 adjusted earnings of $1.50 per share. The Zacks Consensus Estimate was of a loss of 94 cents per share. However, the bottom line declined 32.1% year over year due to lower admissions.

Quarterly Details

HCA Healthcare’s revenues of $11.1 billion beat the Zacks Consensus Estimate by 17.7%. However, the top line declined 12.2% from the year-ago period.

Same facility equivalent admissions tumbled 20.1% year over year while same facility admissions dropped 12.8% year over year. However, same facility revenue per equivalent admission grew 10% year over year.

Same facility inpatient surgeries and same facility outpatient surgeries slid 15.7% and 32.6%, respectively, year over year.

Patient volumes across most services contracted in April due to strict adherence to state and local policies for restricting the spread of COVID-19. However, patient volumes improved in May and June as states began to resume and allow non-emergent procedures.

Salaries and benefits, supplies and other operating expenses decreased 10.6% year over year to $9.2 billion.

Adjusted EBITDA totaled $2.6 billion, up 16.3% year over year.

As of Jun 30, 2020, HCA Healthcare operated 186 hospitals.

HCA Healthcare, Inc. Price, Consensus and EPS Surprise

HCA Healthcare, Inc. Price, Consensus and EPS Surprise
HCA Healthcare, Inc. Price, Consensus and EPS Surprise

HCA Healthcare, Inc. price-consensus-eps-surprise-chart | HCA Healthcare, Inc. Quote

Financial Update

As of Jun 30, 2020, the company had cash and cash equivalents of $4.6 billion, total debt of $30.9 billion and total assets worth $48.7 billion.

In the reported quarter, capex came in at $745 million minus acquisitions.

Cash flows provided by operating activities were $8.72 billion, up 336.8% year over year.

As of Jun 30, 2020, HCA Healthcare had $7.72 billion of availability under its credit facilities.

Zacks Rank

HCA Healthcare carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Upcoming Releases From Medical Sector

Some stocks worth considering from the medical sector with a perfect mix of elements to surpass estimates in the upcoming quarterly releases are as follows:

Centene Corporation CNC currently has an Earnings ESP of +0.88% and a Zacks Rank #3. The company is scheduled to release second-quarter earnings on Jul 28.

Anthem, Inc. ANTM is slated to announce second-quarter earnings on Jul 29. The stock has an Earnings ESP of +3.73% and a Zacks Rank #2 at present.

Molina Healthcare, Inc. MOH is set to report second-quarter earnings on Jul 30. The stock is currently a #2 Ranked player and has an Earnings ESP of +4.08%.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Molina Healthcare, Inc (MOH) : Free Stock Analysis Report
 
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
 
Centene Corporation (CNC) : Free Stock Analysis Report
 
Anthem, Inc. (ANTM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement